In the news
Cost-benefit analysis set for Advate, hemophilia A treatment
December 21, 2020Hemophilia News Today
Related news
In the news
February 16, 2023
60+ healthcare companies on Forbes’ list of best employers
Becker’s Hospital Review
In the news
December 19, 2022
How to Ascend in Your Career (With Erin Feigal)
People Make it Possible podcast
In the news
December 16, 2022
Prime Therapeutics joins other PBMs in adding Humira biosimilars
Becker’s Payer Issues